5-Oxohexahydroquinolines bearing 4-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells

S Ranjbar, FF Lashkarian, M Khoshneviszadeh… - Journal of Molecular …, 2023 - Elsevier
Multidrug resistance (MDR) limits the therapeutic effect of conventional chemotherapeutic
agents as well as novel targeted anticancer drugs. An important mechanism of MDR is the …

(E)-6-(1-alkyloxyiminoalkyl)-5, 8-dimethoxy-1, 4-naphthoquinones: synthesis, cytotoxic activity and antitumor activity

YJ You, Y Kim, GY Song, BZ Ahn - Bioorganic & medicinal chemistry letters, 2000 - Elsevier
All of 13 (E)-6-(1-alkyloxyiminomethyl)-5, 8-dimethoxy-1, 4-naphthoquinone derivatives
synthesized showed high ED50 values, ranging from 0.1 to 0.3 μg/mL against L1210 cells …

Novel 1, 4‑naphthoquinone derivatives induce reactive oxygen species‑mediated apoptosis in liver cancer cells

Y Wang, YH Luo, XJ Piao… - Molecular …, 2019 - spandidos-publications.com
Abstract Derivatives of 1, 4‑naphthoquinone have excellent anti‑cancer effects, but their use
has been greatly limited due to their serious side effects. To develop compounds with …

Novel quinoxaline-2-carbonitrile-1, 4-dioxide derivatives suppress hif1α activity and circumvent mdr in cancer cells

AM Scherbakov, AM Borunov, GI Buravchenko… - Cancer …, 2018 - Taylor & Francis
ABSTRACT A series of 3-aryl/hetarylquinoxaline-2-carbonitrile-1, 4-dioxides was
synthesized and evaluated against breast cancer cell lines in normoxia and hypoxia …

Convenient Synthesis and Anticancer Activity of Methyl 2-[3-(3-Phenyl-quinoxalin-2-ylsulfanyl)propanamido]alkanoates and N-Alkyl 3-((3-Phenyl-quinoxalin-2-yl) …

SM El Rayes, A Aboelmagd, MS Gomaa, IAI Ali… - ACS …, 2019 - ACS Publications
A series of methyl 2-[3-(3-phenyl-quinoxalin-2-ylsulfanyl) propanamido] alkanoates and their
corresponding hydrazides and N-alkyl 3-((3-phenylquinoxalin-2-yl) sulfanyl) propanamides …

A new synthetic antitumor naphthoquinone induces ROS-mediated apoptosis with activation of the JNK and p38 signaling pathways

PDO de Almeida, GSB Jobim… - Chemico-Biological …, 2021 - Elsevier
Quinones are plant-derived secondary metabolites that present diverse pharmacological
properties, including antibacterial, antifungal, antiviral, anti-inflammatory, antipyretic and …

Synthesis and multidrug resistance reversal activity of 1, 2-disubstituted tetrahydroisoquinoline derivatives

A Mihályi, R Gáspár, Z Zalán, L Lázár, F Fülöp… - Anticancer …, 2004 - ar.iiarjournals.org
Background: Cancer treatment often fails due to multidrug resistance (MDR) of the tumor
cells. One of the major causes is overexpression of P-glycoprotein (P-gp). Materials and …

Molecular docking studies, biological and toxicity evaluation of dihydroisoquinoline derivatives as potential anticancer agents

J Ziemska, A Guśpiel, J Jarosz… - Bioorganic & Medicinal …, 2016 - Elsevier
We report a study of a series of isoquinoline derivatives, including their synthesis, in vitro
microsomal leucine aminopeptidase (LAP) inhibition and antiproliferative activity on cancer …

Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents

S Poudapally, S Battu, LR Velatooru, MS Bethu… - Bioorganic & medicinal …, 2017 - Elsevier
A robust economic approach to N-(quinazoline-4-yl) sulfonamides was developed and
synthesized different aryl, hetero aryl, alkyl and cyclopropyl sulfonamides in excellent yields …

Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives …

Q Qiu, B Liu, J Cui, Z Li, X Deng, H Qiang… - Journal of Medicinal …, 2017 - ACS Publications
P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) is a principal obstacle for
successful cancer chemotherapy. A novel P-gp inhibitor with a quinazoline scaffold, 12k …